MADISON, Wis.--PE Biosystems and privately-held Third Wave Technologies have agreed to terminate their merger agreement that was announced in January because the US government approval was taking too long. Both companies will continue to collaborate.
PE was going to buy Third Wave for 1.972 million shares of PE Biosystems Group stock in a deal valued at $330 million.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
